tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Douglas Miehm, 18 are a HOLD (34.62%), 34 are a BUY (65.38%).
Analyst Douglas Miehm, currently employed at RBC, carries an average stock price target met ratio of 41.76% that have a potential upside of 29.07% achieved within 109 days.
Douglas Miehm’s has documented 104 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BLCO, Bausch + Lomb Corp at 04-Apr-2025.
Analyst best performing recommendations are on AUPH (AURINIA PHARMACEUTICALS).
The best stock recommendation documented was for BHC (BAUSCH HEALTH COMPANIES) at 5/5/2023. The price target of $8 was fulfilled within 13 days with a profit of $2.17 (37.22%) receiving and performance score of 28.63.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$13
$5.19 (66.45%)
$13
7 months 5 days ago
(06-Sep-2024)
10/22 (45.45%)
$5.74 (79.06%)
579
Hold
$6
$-1.81 (-23.18%)
$26
11 months 9 days ago
(02-May-2024)
3/3 (100%)
$0.83 (16.05%)
398
Buy
$8
$0.19 (2.43%)
$11
1 years 1 months 26 days ago
(16-Feb-2024)
8/12 (66.67%)
$2.15 (36.75%)
152
Hold
$13
2 years 5 months 7 days ago
(04-Nov-2022)
5/9 (55.56%)
$4.73 (57.19%)
203
Buy
$12
$4.19 (53.65%)
$22
2 years 5 months 7 days ago
(04-Nov-2022)
1/4 (25%)
$6.85 (133.01%)
266
Which stock is Douglas Miehm is most bullish on?
Which stock is Douglas Miehm is most reserved on?
What Year was the first public recommendation made by Douglas Miehm?
